M. Kathleen Behrens, Director at AVI BIOPHARMA INC (AVII), bought 100,000 shares at $1.50 ($150K) on 2011-04-06, disclosed to the SEC on 2011-04-06.
Open-market purchase of $150k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |